Apr. 13, 2021
WuXi Biologics Receives 2021 Asia-Pacific Bioprocessing Excellence Award from IMAPAC
Press Releases
-
Awards
-
News
Apr. 08, 2021WuXi Biologics Receives GMP Conformity Assessment from the Singapore Health Sciences Authority (HSA) -
News
Apr. 07, 2021WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA -
News
Mar. 23, 20212020 Results Record High Despite a Challenging Year -
Collaboration
Mar. 19, 2021WuXi Biologics Forms Strategic Partnership with Worg Pharma based on Microbial and Viral Platforms -
Collaboration
Mar. 18, 2021WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC Group -
News
Mar. 17, 2021WuXi Biologics to Acquire Biologics DS and DP Manufacturing Facilities from Pfizer China -
Business
Mar. 16, 2021WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19 -
Collaboration
Mar. 08, 2021Exelixis Enters into Exclusive License Agreement with WuXi Biologics to Support Further Expansion of its Growing Oncology Biologics Pipeline
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?